AML (Acute Myeloid Leukemia),Leukemia Improved Outcomes With 131I-Apamistamab in TP53-Mutant AML Jun 19, 2024
AML (Acute Myeloid Leukemia),Leukemia Predicting AML Outcomes With Lysosome-Related Gene Profiles Jun 18, 2024
AML (Acute Myeloid Leukemia),Leukemia Fraxetin: Multitarget Inhibition for AML Cell Control Jun 12, 2024
AML (Acute Myeloid Leukemia),Leukemia Cardiovascular Complications in AML-DIC: Monitoring & Intervene Jun 10, 2024
AML (Acute Myeloid Leukemia),Leukemia Best Transplant Choices for Low and Intermediate-Risk AML Jun 04, 2024
AML (Acute Myeloid Leukemia),Leukemia Prognostic Role of EMI and GO Treatment in Pediatric AML May 27, 2024
AML (Acute Myeloid Leukemia),Leukemia Venetoclax and Hypomethylating Agents vs HAG in AML May 20, 2024